Isoray Inc (ISR) 2.09 $ISR
Stocks Creating Buzz Today
ACCESSWIRE - Fri Sep 19, 1:04PM CDT
Deerfield Beach, FL / Sept 19, 2014 / The Federal Reserve's monetary policy meeting was the talking point at the start of this week. All eyes were on Fed's monetary policy statement, which was released on Wednesday. The Fed surprised the market by maintaining its dovish stance and saying there is considerable time before an interest rate hike.
ONP, UEC, NMM, BCA, ENTG, ISR Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Sep 15, 4:10AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Orient Paper Inc (NYSE:ONP), Uranium Energy Corp (NYSE:UEC), Navios Maritime Partners LP (NYSE:NMM), Corpbanca Sociedad Anonima Bancaria (NYSE:BCA), Entegris Inc (NASDAQ:ENTG), IsoRay Inc (NYSE:ISR) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
Hot Stock: IsoRay, Shares Gain 5.2% (ISR)
Comtex SmarTrend(R) - Fri Sep 12, 11:37AM CDT
IsoRay (AMEX:ISR) is one of today's best performing low-priced stocks, up 5.2% to $2.43 on 1.1x average daily volume. IsoRay has traded 718,000 shares thus far today, vs. average volume of 680,000 shares per day. The stock has outperformed the Dow (5.2% to the Dow's -0.3%) and outperformed the S&P 500 (5.2% to the S&P's -0.4%) during today's trading.
IsoRay's Cesium-131 Cancer Treatment Products and Methods to Be Featured in Oral Presentations by Industry Leaders During the American Society for Radiation Oncology Convention (ASTRO)
Marketwire - Tue Sep 09, 7:30AM CDT
IsoRay Inc. (NYSE MKT: ISR) (www.isoray.com), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it will host a booth at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO). The annual meeting will take place September 14-17, 2014 in San Francisco, California at the Moscone Center, where papers, a panel discussion and dinner presentations are scheduled to be presented on results achieved using IsoRay's products.
ISORAYS CESIUM-131 CANCER TREATMENT PRODUCTS AND METHODS TO BE FEATURED IN ORAL PRESENTATIONS BY INDUSTRY LEADERS DURING THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY CONVENTION (ASTRO)
eTeligis - Tue Sep 09, 7:17AM CDT
NEW YORK CITY, NY, United States, via ETELIGIS INC., 09/09/2014 - - IsoRay Inc. (NYSE MKT: ISR) (www.isoray.com), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it will host a booth at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO). The annual meeting will take place September 14-17, 2014 in San Francisco, California at the Moscone Center, where papers, a panel discussion and dinner presentations are scheduled to be presented on results achieved using IsoRay's products.
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay
PR Newswire - Wed Sep 03, 8:05AM CDT
The US markets on Tuesday, September 02, 2014 ended on a mixed note as the Dow Jones Industrial Average finished at 17,067.56, down 0.18% and the NASDAQ Composite closed at 4,598.19, up 0.39%. The S&P 500 finished the session 0.05% lower at 2,002.28. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 737.75, up 0.02%, with the index gaining 6.88% in the previous three months. Investor-Edge has initiated coverage on the following equities: Galena Biopharma Inc. (NASDAQ: GALE), Gilead Sciences Inc. (NASDAQ: GILD), MannKind Corporation (NASDAQ: MNKD), Orexigen Therapeutics Inc. (NASDAQ: OREX), and IsoRay Inc. (NYSE MKT: ISR). Free research on these five companies can be accessed at:
Top Swing Trade Ideas for Thursday, Aug. 21: Alcoa, Sodastream, More
at The Street - Thu Aug 21, 9:45AM CDT
Alcoa, SodaStream and IsoRay are our big swing trades for Thursday. So how should investors buy and sell?
Hot Stock: IsoRay, Shares Gain 10.7% (ISR)
Comtex SmarTrend(R) - Tue Aug 05, 10:08AM CDT
IsoRay (AMEX:ISR) is one of today's best performing low-priced stocks, up 10.7% to $2.64 on 1.0x average daily volume. IsoRay has traded 2.6 million shares thus far today, vs. average volume of 2.5 million shares per day. The stock has outperformed the Dow (10.5% to the Dow's -0.4%) and outperformed the S&P 500 (10.5% to the S&P's -0.4%) during today's trading.
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery
Marketwire - Tue Aug 05, 7:32AM CDT
IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the publication of the first major peer reviewed study showing superior results using IsoRay's Cesium-131 seeds in the treatment of metastatic brain cancer.
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences
PR Newswire - Thu Jul 31, 7:40AM CDT
On Wednesday, July 30, 2014, the NASDAQ Composite ended at 4,462.90, up 0.45%, the Dow Jones Industrial Average finished the day 0.19% lower at 16,880.36, and the S&P 500 closed at 1,970.07, up 0.01%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 718.94, up 0.36%, and the index has advanced 2.05% in the last one month. Investor-Edge has initiated coverage on the following equities: IsoRay Inc. (NYSE MKT: ISR), Neurocrine Biosciences Inc. (NASDAQ: NBIX), OPKO Health Inc. (NYSE: OPK), Orexigen Therapeutics Inc. (NASDAQ: OREX), and Gilead Sciences Inc. (NASDAQ: GILD). Free research on these five companies can be accessed at:
Why IsoRay (ISR) Stock Is Spiking Today
at The Street - Mon Jul 14, 10:41AM CDT
IsoRay (ISR) shares are climbing after the company's Cesium-131 internal radiation seeds were used in the world's first successful stereotactic brain implant surgery.
IsoRay Makes First Cesium-131 Delivery for Treatment of an Inoperable Brain Cancer Afflicting a Young Child in Peru
Marketwire - Mon Jul 14, 7:30AM CDT
IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the first Cesium-131 seed shipment to Peru for the treatment of a Glioma brain tumor located near the brainstem.
IsoRay Announces Its Addition to the Russell Microcap Index
Marketwire - Mon Jun 30, 7:45AM CDT
IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for cancers of the brain, lung, head and neck, prostate and gynecologic ("gyn"
, today announced that it has been added to the Russell Microcap Index.
A Beaten-Down Biotech Stock Gearing Up for a Big Squeeze Higher
at The Street - Tue Jun 24, 1:22PM CDT
The shorts are betting against this biotech stock, but its technical chart is telling a different story.
Traders Get Bullish on Shares of IsoRay, Shares Up 15.2% (ISR)
Comtex SmarTrend(R) - Tue Jun 24, 10:09AM CDT
IsoRay (AMEX:ISR) is one of today's best performing low-priced stocks, up 15.2% to $3.08 on 5.1x average daily volume. IsoRay has traded 9.9 million shares thus far today, vs. average volume of 1.9 million shares per day. The stock has outperformed the Dow (15.2% to the Dow's 0.1%) and outperformed the S&P 500 (15.2% to the S&P's 0.3%) during today's trading.
Why IsoRay (ISR) Stock Is Surging Today
at The Street - Tue Jun 24, 9:38AM CDT
IsoRay (ISR) surged Tuesday after the company announced the world's first liquid cesium-131 treatment for metastatic brain cancer.
Stocks Creating Buzz Today
ACCESSWIRE - Fri Sep 19, 1:04PM CDT
Deerfield Beach, FL / Sept 19, 2014 / The Federal Reserve's monetary policy meeting was the talking point at the start of this week. All eyes were on Fed's monetary policy statement, which was released on Wednesday. The Fed surprised the market by maintaining its dovish stance and saying there is considerable time before an interest rate hike.
ONP, UEC, NMM, BCA, ENTG, ISR Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Sep 15, 4:10AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Orient Paper Inc (NYSE:ONP), Uranium Energy Corp (NYSE:UEC), Navios Maritime Partners LP (NYSE:NMM), Corpbanca Sociedad Anonima Bancaria (NYSE:BCA), Entegris Inc (NASDAQ:ENTG), IsoRay Inc (NYSE:ISR) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
Hot Stock: IsoRay, Shares Gain 5.2% (ISR)
Comtex SmarTrend(R) - Fri Sep 12, 11:37AM CDT
IsoRay (AMEX:ISR) is one of today's best performing low-priced stocks, up 5.2% to $2.43 on 1.1x average daily volume. IsoRay has traded 718,000 shares thus far today, vs. average volume of 680,000 shares per day. The stock has outperformed the Dow (5.2% to the Dow's -0.3%) and outperformed the S&P 500 (5.2% to the S&P's -0.4%) during today's trading.
IsoRay's Cesium-131 Cancer Treatment Products and Methods to Be Featured in Oral Presentations by Industry Leaders During the American Society for Radiation Oncology Convention (ASTRO)
Marketwire - Tue Sep 09, 7:30AM CDT
IsoRay Inc. (NYSE MKT: ISR) (www.isoray.com), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it will host a booth at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO). The annual meeting will take place September 14-17, 2014 in San Francisco, California at the Moscone Center, where papers, a panel discussion and dinner presentations are scheduled to be presented on results achieved using IsoRay's products.
ISORAYS CESIUM-131 CANCER TREATMENT PRODUCTS AND METHODS TO BE FEATURED IN ORAL PRESENTATIONS BY INDUSTRY LEADERS DURING THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY CONVENTION (ASTRO)
eTeligis - Tue Sep 09, 7:17AM CDT
NEW YORK CITY, NY, United States, via ETELIGIS INC., 09/09/2014 - - IsoRay Inc. (NYSE MKT: ISR) (www.isoray.com), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it will host a booth at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO). The annual meeting will take place September 14-17, 2014 in San Francisco, California at the Moscone Center, where papers, a panel discussion and dinner presentations are scheduled to be presented on results achieved using IsoRay's products.
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay
PR Newswire - Wed Sep 03, 8:05AM CDT
The US markets on Tuesday, September 02, 2014 ended on a mixed note as the Dow Jones Industrial Average finished at 17,067.56, down 0.18% and the NASDAQ Composite closed at 4,598.19, up 0.39%. The S&P 500 finished the session 0.05% lower at 2,002.28. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 737.75, up 0.02%, with the index gaining 6.88% in the previous three months. Investor-Edge has initiated coverage on the following equities: Galena Biopharma Inc. (NASDAQ: GALE), Gilead Sciences Inc. (NASDAQ: GILD), MannKind Corporation (NASDAQ: MNKD), Orexigen Therapeutics Inc. (NASDAQ: OREX), and IsoRay Inc. (NYSE MKT: ISR). Free research on these five companies can be accessed at:
Top Swing Trade Ideas for Thursday, Aug. 21: Alcoa, Sodastream, More
at The Street - Thu Aug 21, 9:45AM CDT
Alcoa, SodaStream and IsoRay are our big swing trades for Thursday. So how should investors buy and sell?
Hot Stock: IsoRay, Shares Gain 10.7% (ISR)
Comtex SmarTrend(R) - Tue Aug 05, 10:08AM CDT
IsoRay (AMEX:ISR) is one of today's best performing low-priced stocks, up 10.7% to $2.64 on 1.0x average daily volume. IsoRay has traded 2.6 million shares thus far today, vs. average volume of 2.5 million shares per day. The stock has outperformed the Dow (10.5% to the Dow's -0.4%) and outperformed the S&P 500 (10.5% to the S&P's -0.4%) during today's trading.
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery
Marketwire - Tue Aug 05, 7:32AM CDT
IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the publication of the first major peer reviewed study showing superior results using IsoRay's Cesium-131 seeds in the treatment of metastatic brain cancer.
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences
PR Newswire - Thu Jul 31, 7:40AM CDT
On Wednesday, July 30, 2014, the NASDAQ Composite ended at 4,462.90, up 0.45%, the Dow Jones Industrial Average finished the day 0.19% lower at 16,880.36, and the S&P 500 closed at 1,970.07, up 0.01%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 718.94, up 0.36%, and the index has advanced 2.05% in the last one month. Investor-Edge has initiated coverage on the following equities: IsoRay Inc. (NYSE MKT: ISR), Neurocrine Biosciences Inc. (NASDAQ: NBIX), OPKO Health Inc. (NYSE: OPK), Orexigen Therapeutics Inc. (NASDAQ: OREX), and Gilead Sciences Inc. (NASDAQ: GILD). Free research on these five companies can be accessed at:
Why IsoRay (ISR) Stock Is Spiking Today
at The Street - Mon Jul 14, 10:41AM CDT
IsoRay (ISR) shares are climbing after the company's Cesium-131 internal radiation seeds were used in the world's first successful stereotactic brain implant surgery.
IsoRay Makes First Cesium-131 Delivery for Treatment of an Inoperable Brain Cancer Afflicting a Young Child in Peru
Marketwire - Mon Jul 14, 7:30AM CDT
IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the first Cesium-131 seed shipment to Peru for the treatment of a Glioma brain tumor located near the brainstem.
IsoRay Announces Its Addition to the Russell Microcap Index
Marketwire - Mon Jun 30, 7:45AM CDT
IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for cancers of the brain, lung, head and neck, prostate and gynecologic ("gyn"
, today announced that it has been added to the Russell Microcap Index. A Beaten-Down Biotech Stock Gearing Up for a Big Squeeze Higher
at The Street - Tue Jun 24, 1:22PM CDT
The shorts are betting against this biotech stock, but its technical chart is telling a different story.
Traders Get Bullish on Shares of IsoRay, Shares Up 15.2% (ISR)
Comtex SmarTrend(R) - Tue Jun 24, 10:09AM CDT
IsoRay (AMEX:ISR) is one of today's best performing low-priced stocks, up 15.2% to $3.08 on 5.1x average daily volume. IsoRay has traded 9.9 million shares thus far today, vs. average volume of 1.9 million shares per day. The stock has outperformed the Dow (15.2% to the Dow's 0.1%) and outperformed the S&P 500 (15.2% to the S&P's 0.3%) during today's trading.
Why IsoRay (ISR) Stock Is Surging Today
at The Street - Tue Jun 24, 9:38AM CDT
IsoRay (ISR) surged Tuesday after the company announced the world's first liquid cesium-131 treatment for metastatic brain cancer.
